Loading patent…
AssigneesNew York University, BioKeys for Flavors, LLC
InventorsIvica Labuda, Fredric Jay Burns
Estimating the term…
The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by ultraviolet radiation (UVR). More specifically it provides terpenes and terpenoids as ingredients that work as persistent UVR blockers. Terpenes and terpenoid compounds support the growth of skin, skin tissue and keratinocytes and additional UVR-blocking by reason of increased stratum corneum thickness and loricrin content. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 6 mg to about 600 mg per kilogram of body weight per day effective to stimulate growth of the skin layer and prevent damage from ultraviolet radiation (UVR).
A method of increasing the amount of ultraviolet radiation (UVR) that the skin can block or absorb comprising administering a terpene wherein the terpene is administered prior to exposure to UVR.
A method of increasing the amount of ultraviolet radiation (UVR) that the skin can block or absorb comprising orally administering a terpene.
A method of increasing the amount of ultraviolet radiation (UVR) that the skin can block or absorb comprising administering a terpene in a dosage and in amounts sufficient to increase epidermal cell proliferation and increase keratin production in the skin of subjects receiving the terpene compared to the amount of epidermal cell proliferation and keratin production present in the skin of subjects not receiving the terpene when both subjects or both sets of subjects are exposed to the same dosage of UVR.
A method of increasing the amount of ultraviolet radiation (UVR) that the skin can block or absorb comprising administering a terpene in a dosage and in amounts sufficient to alter the expression of one or more gene products selected from the group consisting of NFKappaB, COX1, COX2, MAPKS, PGE2, ODC, protein kinase C, INOS, PI3-AKT, TNF-A, AP1, NRF2, KEAP1 and IKappa kinase.
Dependencies are inferred from the claim text.